RAD52 delins carriers from the hereditary cohort were diagnosed with breast cancer at the age of 26, 28, 34, 36, 47, 54 and 78, respectively (mean 43 years), the mean for this cohort otherwise being 45 years (range 26–89 years). Here, RAD52 is linked to breast carcinoma.